Cypress Capital’s Eli Lilly LLY Stock Holding History

Cypress Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$875K	Buy	756 +10	+1%	+$11.8K	0.23%	57
2026 Q2	$895K	Sell	746 -6	-0.8%	-$6.13K	0.24%	59
2026 Q1	$692K	Buy	752 +3	+0.4%	+$3.04K	0.2%	58
2025 Q4	$805K	Sell	749 -43	-5%	-$41.1K	0.23%	55
2025 Q3	$604K	Buy	792 +114	+17%	+$84.8K	0.17%	66
2025 Q2	$529K	Buy	678 +169	+33%	+$131K	0.15%	62
2025 Q1	$420K	Sell	509 -73	-13%	-$60.7K	0.12%	67
2024 Q4	$449K	Buy	582 +11	+2%	+$9.11K	0.13%	60
2024 Q3	$506K	Sell	571 -513	-47%	-$461K	0.13%	61
2024 Q2	$981K	Buy	1,084 +555	+105%	+$444K	0.25%	52
2024 Q1	$412K	Buy	529 +2	+0.4%	+$1.42K	0.11%	64
2023 Q4	$307K	Sell	527 -32	-6%	-$18.7K	0.09%	68
2023 Q3	$300K	Buy	559 +3	+0.5%	+$1.55K	0.09%	66
2023 Q2	$261K	Buy	+556	New	+$233K	0.08%	68

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Cypress Capital's LLY Position: Q3 2026 in Review

Cypress Capital increased its Eli Lilly (LLY) stake by 1.3% in Q3 2026, buying an estimated $11.8K and bringing the position to 756 shares worth $875K. The position accounts for 0.23% of the portfolio, ranked #57.

Cypress Capital first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. The position peaked at $981K in Q2 2024. 1,048 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Cypress Capital held 756 shares of Eli Lilly worth $875K as of Q3 2026.
Cypress Capital bought 10 Eli Lilly shares in Q3 2026, an estimated $11.8K.
Eli Lilly made up 0.23% of Cypress Capital's portfolio in Q3 2026, its #57 holding.
Cypress Capital first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
Cypress Capital's Eli Lilly position peaked at $981K in Q2 2024.
1,048 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cypress Capital's 13F filing for Q3 2026, filed 20 Oct 2026.